期刊文献+

Alzheimer病与视网膜变性 被引量:4

Alzheimer's disease and retinal degeneration
原文传递
导出
摘要 Alzheimer病(Alzheimer's disease,AD)是一种进行性神经变性疾病,它是导致老年痴呆的主要原因且至今无法治愈.β淀粉样蛋白斑块沉积和tau蛋白引起的神经纤维缠结是导致AD患者大脑病变的两大主要机制.近来发现越来越多的AD患者除了意识和行为障碍,还存在眼部症状.有研究表明AD相关的β淀粉样蛋白斑块不仅沉积于大脑,同时累及视网膜,且视网膜病变较大脑病变更易观察诊断.因此,研究AD相关的视网膜变性不仅有助于深入了解脑部病变过程,为AD提供一种全新的简单有效的诊疗方法,也有益于研究如青光眼和年龄相关性黄斑变性等其他视网膜变性类疾病的病理机制. Alzheimer's disease (AD),a devastating neurodegenerative disease,is the primary cause of dementia with no cure available.Amyloid plaques and neurofibrillary tangles underlie the two pathological hallmarks in AD brain.In addition to cognitive and behavioral deficits,vision abnormalities are prevalent in AD patients.While most AD related pathology occurs in the brain,the disease has also been reported to affect the retina,which is more accessible for imaging than the brain.Therefore,studying AD-related retinal degeneration is a promising way for the investigation on AD pathologies and therapies that would eventually benefit the brain and cellular mechanisms in other retinal degenerations such as glaucoma and age-related macular degeneration.
作者 李晓 张卯年
出处 《国际眼科纵览》 2013年第4期260-264,共5页 International Review of Ophthalmology
关键词 ALZHEIMER病 视网膜变性 Β淀粉样蛋白 Alzheimer's disease retina degeneration β-amyloid
  • 相关文献

参考文献36

  • 1Marchesi VT. Alzheimer~s disease 2012: the great amyloid gam- ble. Am J Ophthalmol, 2012, 180: 1762-1767. 被引量:1
  • 2Huang Y, Mucke L. Alzheimer mechanisms and therapeutic strat- egies. Cell, 2012, 148:1204-1222. 被引量:1
  • 3Brookmeyer R, Johnson E, Ziegler-Graham K, et al. Forecasting the global burden of Alzheimer ~s disease. Alzheimers Dement, 2007, 3 : 186-191. 被引量:1
  • 4Cummings JL, Cole G. Alzheimer disease. JAMA, 2002, 287 : 2335-2338. 被引量:1
  • 5Kirby E, Bandelow S, Hogervorst E. Visual impairment in Alzhei- mer~ disease: a critical review. J Alzheimers Dis, 2010, 21:15-34. 被引量:1
  • 6Valenti DA. Alzheimer's disease: visual system review. Optome- try, 2010, 81:12-21. 被引量:1
  • 7Mandal PK, Joshi J, Saharan S. Visuospatial perception: an e- merging biomarker for Alzheimer "s disease. J Alzheimers Dis, 2012, 31 ( Suppl 3) :S117-135. 被引量:1
  • 8McKee AC, Au R, Cabral HJ, et al. Visual association pathology in preelinical Alzheimer disease. J Neuropathol Exp Neural, 2006, 65:621-630. 被引量:1
  • 9Frost S, Martins RN, Kanagasingam Y. Ocular biomarkers for ear- ly detection of Alzheimer~ disease. J Alzheimers Dis, 2010, 22 : 1 - 16. 被引量:1
  • 10Koronyo-Hamaoui M, Koronyo Y, Ljubimov AV, et al. Identifi- cation of amyloid plaques in retinas from Alzheimer~ patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Neuroimage, 2011, 54(Suppl 1 ) :$204-217. 被引量:1

同被引文献76

  • 1王春艳,郭景森,田晶,崔万丽.β淀粉样蛋白与阿尔茨海默病[J].吉林医药学院学报,2009,30(2):99-102. 被引量:9
  • 2Armstrong RA. Alzheimer's disease and the eye [J]. J Optom, 2009,2(3) : 103-111. 被引量:1
  • 3Sathya M, Premkumar P, Karthiek C, et al. Baeel in Alzheimer's disease [J]. Clin Chim Acta, 2012,414:171-178. 被引量:1
  • 4Iqbal K, Alonso Adel C, Chen S, et al. Tau pathology in Alzheimer disease and other tauopathies [J]. Biochim Biophys Acta, 2005,1739(2-3) :198-210. 被引量:1
  • 5Priller C, Bauer T, Mitteregger G, et al. Synapse formation and function is modulated by the amyloid precursor protein [J]. J Neurosci, 2006,26(27) :7212-7221. 被引量:1
  • 6Ninomiya H, Roch JM, Sundsmo MP, et ah Amino acid sequence rerms represents the active domain of amylold beta/a4 protein precursor that promotes fibroblast growth [J]. J Cell Biol, 1993,121(4) :879-886. 被引量:1
  • 7Tzekov R, Mullah M. Vision function abnormalities in Alzheimer disease [J]. Surv Ophthalmol, 2014,59(4):414-433. 被引量:1
  • 8Younkin SG. Evidence that a beta 42 is the real culprit in Alzheimer's disease [J]. Ann Neurol, 1995,37(3):287-288. 被引量:1
  • 9Koronyo Y, Salumbides BC, Black KL, et al. Alzheimer's disease in the retina: imaging retinal abeta plaques for early diagnosis and therapy assessment [J]. Neurodegener Dis, 2012, 10(1-4):285-293. 被引量:1
  • 10Hyman BT, Trojanowski JQ. Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the national institute on aging and the reagan institute working group on diagnostic criteria for the neuropathological assessment of Alzheimer disease [J]. J Neuropathol Exp Neurol, 1997, 56 (10) : 1095-1097. 被引量:1

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部